AVAVA
Neeil Gandhi is an Associate Engineer at AVAVA since November 2024, previously serving as an Imaging Application Engineer at LifeCanvas Technologies Inc. from August 2023 to November 2024. Prior experience includes work as a Graduate Research Assistant at the Wilmer Eye Institute, Johns Hopkins Medicine, from September 2022 to July 2023, and a Research and Development Intern at GME German Medical Engineering GmbH, where projects focused on medical devices for skin conditions. Neeil held positions as an Undergraduate Research Assistant at CREOL, The College of Optics & Photonics, and the NanoScience Technology Center at the University of Central Florida, as well as roles in student support and marketing at Shorelight and Aramark. Neeil earned a Master of Science in Biomedical/Medical Engineering from the Johns Hopkins Whiting School of Engineering and a Bachelor's degree in Photonics Science and Engineering with a minor in Finance from the University of Central Florida.
This person is not in any teams
AVAVA
AVAVA™ developed a new class of FDA-cleared, non-invasive aesthetic medical devices with patented precision technology to provide best in class patient and provider experience for all skin tones. The AVAVA proprietary Focal Point Technology™ is complemented by AVAVASite, a high-resolution interactive imaging system, which provides treatment intelligence to map and guide real-time therapy with actionable data, to unlock safe and effective treatments. AVAVA received FDA Clearance 510(k) for its first two devices in 2022, the first of which, MIRIA™ will have a limited release in 2023 with broad scale commercial availability in 2024. The MIRIA System is a high energy focused intradermal laser, powered by Focal Point Technology™, that delivers energy at any depth in the skin with pinpoint accuracy, making it ideal for patients with darker skin tones. The MIRIA System delivers a high dose of conical energy to the dermis and spares the sensitive epidermis from unwanted damage — all while maintaining patient comfort and with minimal downtime. Extensive MIRIA clinical studies have demonstrated improvement in all signs of skin aging, including wrinkles, sun damage, and skin quality, as well as reduction in pitted acne scarring and large pore size across a wide range of skin types and colors. The MIRIA by AVAVA System™ will help address the needs of over 11.7 million US-individuals of all skin tones that seek facial rejuvenation each year.